DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Serevent (Salmeterol Xinafoate) - Current Clinical Trials

 
 



Serevent Related Clinical Trials

Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography [Recruiting]

Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients [Completed]

Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate [Completed]

A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149 [Completed]

A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER« Inhaler Relative to the DISKUS« Inhaler [Withdrawn]

Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway [Completed]

Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients [Completed]

Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit [Completed]

A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma [Completed]

QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control [Completed]

Effects of Salmeterol on Walking Capacity in Patients With COPD [Completed]

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus [Recruiting]

Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma [Completed]

Effects of Particle Size in Small Airways Dysfunction [Completed]

Comparison of Two Treatment Regimens in Asthmatic Patients [Completed]

Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Tiotropium/Salmeterol Inhalation Powder in COPD [Terminated]

Impact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in Smokers [Completed]

Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma [Not yet recruiting]

Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma [Completed]

Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol PE Capsule) in COPD [Terminated]

Tiotropium and Salmeterol PK Study in COPD Patients [Completed]

Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT) [Completed]

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.) [Completed]

Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Compare the Effects of Seretide« Evohaler and a Generic Salmeterol/Fluticasone Hydrofluoroalkane (HFA) Pressurized Metered-dose Inhaler (pMDI) on Functional Respiratory Imaging Parameters in Asthmatic Patients [Completed]

A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma [Completed]

Long-acting Beta Agonist Step Down Study [Active, not recruiting]

Efficacy and Safety of Different Doses of Indacaterol [Completed]

A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD [Withdrawn]

A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics [Not yet recruiting]

Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange [Completed]

A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients [Recruiting]

A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort [Not yet recruiting]

Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma [Recruiting]

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. [Completed]

Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol [Completed]

Study of the Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations [Terminated]

Fluticasone and Salmeterol in Allergic Rhinitis [Completed]

Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies [Completed]

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316) [Completed]

HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents [Completed]

A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD [Withdrawn]

The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD [Withdrawn]

Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids [Completed]

Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma [Active, not recruiting]

Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 ┬Ág BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV [Completed]

Pharmacogenetics of b2-Agonists in Asthma. [Completed]

Comparing Fluticasone-Salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep [Not yet recruiting]

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma [Recruiting]

ROTAHALER Device Optimization Study [Completed]

Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD [Completed]

Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD [Recruiting]

Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients [Completed]

Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) [Completed]

Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Viapaed Study In Children And Adolescents With Asthma [Completed]

Advair« DISKUS« Versus Serevent« DISKUS« For Chronic Obstructive Pulmonary Disease Exacerbations [Completed]

Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair [Completed]

Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study- [Completed]

EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 ´┐Żg + FORMOTEROL 6 ´┐Żg pMDI VIA HFA-134a vs. FLUTICASONE 125 ´┐Żg + SALMETEROL 25 ´┐Żg pMDI [Completed]

Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks [Completed]

Advair HFA For Chronic Obstructive Pulmonary Disease(COPD) [Completed]

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus [Completed]

Study to Evaluate Small Airway Parameters of Fluticasone/Formoterol (Flutiform«) Compared to Fluticasone/Salmeterol in Asthma Patients [Recruiting]

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus [Completed]

Advair« DISKUS« (Fluticasone Propionate/Salmeterol) Versus Serevent« DISKUS« (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations [Completed]

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE With An Adjustable Maintenance Dose Of SYMBICORT [Completed]

Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD) [Completed]

A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations [Completed]

A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study [Completed]

Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease [Completed]

Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD [Completed]

Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015